Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSVWI7)

• Drug Name: Neladenoson bialanate Drug Info
• Synonyms: UNII-IV690462VZ; IV690462VZ; 1239309-58-0; Neladenoson dalanate; Neladenoson dalanate [INN]; Neladenoson bialanate [INN]; SCHEMBL7904070; AKOS032946515; DB13138; L-Alanine, L-alanyl-, 2-(4-(2-(((2-(4-chlorophenyl)-4-thiazolyl)methyl)thio)-3,5-dicyano-6-(1-pyrrolidinyl)-4-pyridinyl)phenoxy)ethyl ester; 2-(4-(2-(((2-(4-Chlorophenyl)-1,3-thiazol-4-yl)methyl)sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl)phenoxy)ethyl L-alanyl-L-alaninate

Indication

Disease Entry	ICD 11	Status	REF
Chronic heart failure	BD1Z	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 56848985
  CAS Number: CAS 1239309-58-0
  TTD Drug ID: DMSVWI7

Molecule-Related Drug Atlas

Drug(s) Targeting ADORA1 messenger RNA (ADORA1 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
EPI-2010	DMJ52FZ	Asthma	CA23	Discontinued in Phase 2	[2]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
ADORA1 messenger RNA (ADORA1 mRNA)	TT92EIB	AA1R_HUMAN	Agonist	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] RASONs: a novel antisense oligonucleotide therapeutic approach for asthma. Expert Opin Biol Ther. 2001 Nov;1(6):979-83.